60.jpeg)
Hyderabad-based vaccine manufacturer Bharat Biotech on Friday announced that is indigenously-developed COVID-19 vaccine COVAXIN has been recognised in Japan with effect from April 10.
"Government of Japan includes the indigenously developed and manufactured COVID-19 vaccine COVAXIN by Bharat Biotech of India, as one of the recognised vaccines for 1st and 2nd dose with effect from 10 April 2022 to further facilitate travel from India to Japan," said the Indian Embassy in Japan on Thursday
139.jpeg)
260.jpeg)
259.jpeg)
258.jpeg)
